Epitel Secures $12.5 Million Series A Financing For Wearable, Wireless EEG Monitoring System

Epitel, Inc., a digital health company developing a wearable, wireless electroencephalogram (EEG) monitoring platform for seizure detection, has closed a $12.5 million Series A financing for initial pilot commercialization and further development of its proprietary platform. Epitel received clearance from the U.S. Food and Drug Administration (FDA) for its first product, a wireless and wearable EEG (brain wave monitor) sensor, and remote access software known as REMI® for use within hospital emergency rooms and critical care units. REMI first received clearance from the FDA in 2021.

REMI, Epitel’s first FDA-cleared product uses wearable, wireless sensors that . . .